Apollo Hospitals, India becomes the first Asian Hospital to pe... - 17 March 2021 00:34

CHENNAI, India, March 16, 2021/PRNewswie-AsiaNet/ The Apollo Hospitals group, one of Asia's largest and most trusted healthcare group, notched up a record milestone with the successful completion of four consecutive MitraClip procedures in one day. The MitraClip implants were carried out on f...

  Merck Reports Topline Data for Bintrafusp Alfa as Second-Line ... - 16 March 2021 18:00

DARMSTADT, Germany, March 16, 2021 /PRNewswire-AsiaNet/ -- - Not intended for US-, Canada- or UK-based media Merck, a leading science and technology company, today announced topline data from the Phase II INTR@PID BTC 047 study evaluating bintrafusp alfa as a monotherapy in the second-line treatment of...

  Agiomix Receives the First ISO 15189 Accreditation for Next Ge... - 15 March 2021 01:22

DUBAI, UAE, March 14, 2021 /PRNewswire-AsiaNet/ -- Agiomix has received the ISO 15189:2012 Accreditation from the Emirates International Accreditation Centre for Next Generation Sequencing clinical assays. This makes Agiomix the first and only clinical laboratory in the region to have both the ...

  Novavax Confirms High Levels of Efficacy Against Original and ... - 12 March 2021 08:41

GAITHERSBURG, Md., March 12, 2021 /PRNewswire-AsiaNet/ -- - 100% protection against severe disease - Final analysis in U.K. trial confirms 96% efficacy against original strain of COVID-19 - Efficacy against variants confirmed in U.K. and South Africa Novavax, Inc. (Nasdaq: NVAX), a biotechnology...

  Zymo Research Receives 510(k) Clearance for its Collection/Tra... - 11 March 2021 18:33

IRVINE, Calif., March 11, 2021 /PRNewswire-AsiaNet/ -- -- The first 510(k)-cleared transport medium for COVID-19 testing Zymo Research announced today the U.S. Food and Drug Administration (FDA) has cleared its DNA/RNA Shield(TM)( https://c212.net/c/link/?t=0&l=en&o=3093867-1&h=368172111&u=https%3A...

  Non-Invasive Liquid Biopsy to Help Cancer Diagnosis Gets CE Ce... - 11 March 2021 07:00

LONDON, March 11, 2021 /PRNewswire-AsiaNet/ -- Datar Cancer Genetics, a global leader in non-invasive cancer diagnostics, has received Conformité Européenne (CE) Mark for its innovative TruBlood solution, a new paradigm in cancer detection, diagnosis and management. TruBlood is a blood-ba...

  Dr. Gu Guoxin Helps Thousands "Be Proud of Your Mouth" This Wo... - 10 March 2021 13:39

SHENZHEN, China, March 10, 2021 /PRNewswire-AsiaNet/ -- Every year, World Oral Health Day (WOHD) empowers people with the tools and knowledge to prevent and control oral diseases through good oral health. In line with this year's theme of World Oral Health Day (WOHD), "Be Proud Of Your Mouth", Dr. Gu G...

  Pepticom's New Spinout Company, PeptiCov, to Focus on COVID-19 - 10 March 2021 11:01

JERUSALEM, March 10, 2021 /PRNewswire-AsiaNet/ -- Pepticom, a leader in artificial intelligence peptide drug design and discovery, announced today that it has raised $2.6 million to establish a company to focus on treatments for the SARS-Cov-2 virus, responsible for the COVID-19 outbreak. The...

  Cytiva and Longitude (a Financial Times company) reveal five m... - 09 March 2021 18:00

AMERSHAM, United Kingdom, March 9, 2021 /PRNewswire-AsiaNet/ -- - A survey of 1,165 biopharma executives and healthcare policymakers across 20 countries measured ability of industry to respond to global needs in five areas: Supply chain resilience, talent pool, R&D ecosystem, manufacturing agility, and governm...

  Patients Win When Support Is Personalized: New Study From Atla... - 08 March 2021 08:00

SYDNEY, March 8, 2021 /PRNewswire-AsiaNet/ -- Leading patient outcomes journal Patient Preference and Adherence [ https://doi.org/10.2147/PPA.S293941 ] has published a study that demonstrates significant improvement in treatment behaviors among patients with neovascular age-related macular de...